A CRISPR-dCas13 RNA-editing tool to study alternative splicing

• Published in: Nucleic acids research Vol. 52; no. 19; pp. 11926 - 11939
• Main Authors: Núñez-Álvarez, Yaiza, Espie-Caullet, Tristan, Buhagiar, Géraldine, Rubio-Zulaika, Ane, Alonso-Marañón, Josune, Luna-Pérez, Elvira, Blazquez, Lorea, Luco, Reini F
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 20.08.2024
• Subjects: Life Sciences; RNA and RNA-protein complexes
• ISSN: 0305-1048; 1362-4962; 1362-4962
• DOI: 10.1093/nar/gkae682

Alternative splicing allows multiple transcripts to be generated from the same gene to diversify the protein repertoire and gain new functions despite a limited coding genome. It can impact a wide spectrum of biological processes, including disease. However, its significance has long been underestimated due to limitations in dissecting the precise role of each splicing isoform in a physiological context. Furthermore, identifying key regulatory elements to correct deleterious splicing isoforms has proven equally challenging, increasing the difficulty of tackling the role of alternative splicing in cell biology. In this work, we take advantage of dCasRx, a catalytically inactive RNA targeting CRISPR-dCas13 ortholog, to efficiently switch alternative splicing patterns of endogenous transcripts without affecting overall gene expression levels cost-effectively. Additionally, we demonstrate a new application for the dCasRx splice-editing system to identify key regulatory RNA elements of specific splicing events. With this approach, we are expanding the RNA toolkit to better understand the regulatory mechanisms underlying alternative splicing and its physiological impact in various biological processes, including pathological conditions.